| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Change Management > There Is A Strong Parallel Between Physical And Fiscal Health |
|
Main Subject - There Is A Strong Parallel Between Physical And Fiscal Health
There is a strong parallel between corporations and medical science. Companies fall sick
just as people do. Contrary to the common view, a company is not an ina According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nimate object.
Rather, it is a community of people, a living organism and an entity with its own
distinctive personality and attitudes. Therefore, without pro ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in er care, a company, which
has a life of its own, will perish. Rather than understanding businesses by using some
mechanical or industrial models, it is useful lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. to understand them from the perspective of
ecology of organisms. Like all organisms, the companies exist primarily for their own
survival and improvement as here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ell as fulfill their full potential. Similarly, as human
beings, we exist to survive and thrive. At the antenatal stage, just as in the case of the impregnatio d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro n of the human embryo, a
company is incorporated through a concept wherein the founder explores or brainstorms
the initial idea. In the case of the person, th ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc foetus will be nurtured through antenatal
care till birth. For the company it is conceptualized from a feasibility report on its
commercial viability followe easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi d by incubation and culminating in its start up. The
company may have been born out of a merger or acquisition, the social marriage for
corporations. At birth nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically the start up company is a baby. Some babies are stillborn and
aborted due to various congenital defects. Similarly, some start-up companies are
aborted due t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ o lack of funds or breakup in the partnerships. A healthy person is like a profitable company, full of vitality and energy, whereas a patient is akin to a trou ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi led company plagued by problems. The trouble is often financial
in nature. When the company is sick, it needs a corporate doctor for healing or
turnaround. In ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a many cases, the sick company requires fresh injection of funds to
resuscitate it. This is where the company needs to turn to hospital. The hospital is the ban dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod , private investor or venture capitalist which provides vital
financing and cash flow for the sick company to sustain itself. The surgery is known by a
host o cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin f corporate euphemisms such as restructuring, rationalising, downsizing and reengineering. They all mean the same thing. If you have been a victim of re-engineeri tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen g,
it basically means that you have been fired. Companies get attacked by viruses too. These viruses can include incompetent management, low cost competition t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel , economic recession etc. The mindset also affects the
company’s financial health, just as psychosomatic problems can affect the physical health.
Mindsets pro ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust lems include the negative attitude, lack of enthusiasm and a general
dysfunctional corporate culture that is resistant to changes in the marketplace. When a co y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products mpany falls critically ill with a major disease such as loss of competitiveness,
it needs to be admitted into the intensive care unit where it can receive turna . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ound
treatments. When the company is healed, it is successfully turned around; otherwise,
death in the form of financial collapse or bankruptcy ensues. Compan elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip y also has its own
undertaker, it is known as the liquidator, spelling its demise or death. Thus, there are many similarities between fiscal and physical health tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:24 Key Factors to Investigate When Analyzing ANY Business Office Workers and Warm, Breezy Weather Forensic Accounting - CSI of Accounting Jobs
|